Autori: Ohe Yuichiro
| Naslov | Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin (R)) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC) (Meeting Abstract) |
| Autori | Ohe Yuichiro ... Andric Zoran G  ... (broj koautora 17)
|
| Info | CANCER RESEARCH, (2022), vol. 82 br. 12, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa |
     |
| Naslov | Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial (Article) |
| Autori | Verschraegen Claire Andric Zoran G Moiseenko Fedor Makharadze Tamta Shevnya Sergii Oleksiienko Alona Ruiz Eduardo Yanez Kim SungHyun Ahn KeumYoung Park TaeHong Park Sijin Ju Hana Ohe Yuichiro
|
| Info | BIODRUGS, (2022), vol. 36 br. 6, str. 749-760 |
| Projekat | Celltrion, Inc. (Incheon, Republic of Korea) |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
